Ch. 9: CNS problems Flashcards
Sedative Hypnotic medications actions and uses:
relaxes the patient and allows him or her to sleep
Hypnotic agent produces what in the patient?
Sleep
Psychotherapeutic Agents
Antianxiety Medications Antidepressants Antipsychotic Drugs Antimanic Drugs Sedative-Hypnotic Medications
Antianxiety Agents
Anxiety is common, problematic when it interferes with a person’s ability to perform activities of daily living
Action of antianxiety drugs
produce a calming effect
Uses of antianxiety drugs
Relieve anxiety, tension, and fear
May be used to manage alcohol withdrawal symptoms; used preoperatively; used to relieve muscle spasm
Antianxiety agents patient and family teaching
Dosing; appointments and follow-up; adverse reactions; safety with storage; drug and alcohol interactions
Habit-forming: should be used for the shortest time possible
Typical antipsychotic drugs actions and uses
antipsychotic agents act by blocking the action of dopamine in the brain
Used in the treatment of severe mental illness
May be used in combination with major tranquilizers
Expected side effects/adverse reactions of antipsychotic drugs
headache, drowsiness, nausea, constipation and dry mouth/(EPS)–pseudo-Parkinsonism, acute dystonia, akathisia, and tardive dyskinesia
Drug interactions of antipsychotic drugs
acetaminophen, diuretics such as furosemide or hydrochlorothiazide, certain calcium channel blockers, and several antidiabetic agents
Atypical antipsychotic drugs actions and uses
block dopamine 2 or other subtypes of dopamine receptor as well as certain subtypes of serotonin; used primarily for schizophrenia but also can be used for bipolar illnesses and schizoaffective disorder
Atypical antipsychotics side effects/adverse reactions
Insomnia, drowsiness, sexual side effects, dizziness, orthostatic hypotension, constipation and dry mouth
Atypical antipsychotic drug interactions
Drugs that decrease dopamine, alcohol
Antidepressants and Mood stabilizers
Tricyclics MAOIs SSRIs SNRIs Atypical antidepressants
Selective Serotonin Reuptake Inhibitors actions and uses
Act by inhibiting CNS neuronal uptake of serotonin
Used short-term for treatment of outpatients with diagnosis listed as a category of Major Depressive Disorders in the DSM- V
Used long-term for dysthymic and minor depressive disorders
Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) actions and uses
inhibit the reuptake of both serotonin and norepinephrine increasing the concentration of both neurotransmitters available to postsynaptic receptors
Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) side effects/adverse reactions
nausea, dry mouth, loss of appetite, fatigue, drowsiness, sexual side effects/epistaxis (nosebleeds), gastrointestinal bleeding, and liver damage
SNRIs drug interactions
any drug that affects serotonin or norepinephrine, St. John’s wort
Tricyclic antidepressants actions and uses
Believed to inhibit the reuptake of norepinephrine and or/serotonin
To treat endogenous depression; mild depression due to exogenous causes
Tricyclic antidepressants side effects/adverse reactions
dry mouth, drowsiness, constipation, nausea and orthostatic hypotension/cardiac dysrhythmias, heart failure and seizures
Tricyclic antidepressants drug interactions
sedatives
Monoamine Oxidase Inhibitors actions and uses
Monoamine oxidase: naturally occurring enzyme found in the mitochondria of cells; located in nerve endings, kidneys, liver, and intestines; normally acts as catalyst to inactivate dopamine, norepinephrine, epinephrine, and serotonin MAO inhibitors (MAOIs) block inactivation of these biogenic amines, resulting in increased concentrations at neuronal synapses and antidepressant effects
MAOIs side effects/adverse reactions
constipation, headache, dizziness, drowsiness, dry mouth/liver damage, a variety of blood disorders, thoughts of suicide
MAOIs drug interactions
SSRIs, SNRIs, and St. John’s Wort
Mood stabilizers actions and uses
Exact mechanism of lithium’s action is unknown; alters sodium transport at nerve endings and enhances uptake of serotonin and norepinephrine by the cells (inactivates these neurotransmitters)
Mood-stabilizing drug
Used to treat patients with bipolar disorder who are in acute manic phase; prevents recurrent manic episodes
Mood stabilizers side effects/adverse reactions
mild weight gain, increased thirst, increased urine output, dry skin/hypothyroidism, renal failure and diabetes insipidus
Mood stabilizers drug interactions
Diuretics, NSAIDS, antidepressants, and antipsychotic drugs
Excitatory neurotransmitters
ACh, epinephrine, and norepinephrine
Inhibitory neurotransmitters
Dopamine, types of serotonin, and GABA
Parkinson’s Disease
imbalance of excitatory and inhibitory neurotransmitters
Alzheimer’s and Parkinson’s Disease
result from degenerative changes that occur within nerves
PD is a CNS disorder
not enough dopamine, imbalance between excitatory and inhibitory reduced
PD symptoms
tremors, stooped posture, difficulty stopping motion, difficulty chewing, swallowing, and drooling
PD complications
Depression, anxiety, hallucinations, and delusions
PD drugs increase dopamine levels
to improve motor symptoms
Increased dopamine supply results in
hallucinations/delusions
Most common neurodegenerative disease
Parkinson’s
PD drugs
COMT inhibitors and Monoamine Oxidase type B (MAO-B)
Dopamine Agonists
increased levels of dopamine to restore balance between ACh and dopamine action
Carbidopa/Levidopa
Sinemet, Rytary; 1st line treatment for PD patients older than 70 years
Parmipexole, roprinrol, and rotigotine
Mirapex, Mirapex ER, Requip, Neupro; 1st line treatment for PD patients between 50 and 70 years
Levodopa
is synthesized in the brain and converted to natural dopamine
COMT inhibitors
Entacapone (Comtan), tolcapone (Tasmar)
Selective MAO-B
breaks down dopamine; rasagiline (Azilect), safinamide (Xadago), selegiline (Eldepryl, Ensam, Zelapan)
Dyskinesia
involuntary muscle movements common in patients on long-term carbidopa/levidopa therapy
Delirium
psychosis and hallucinations, caused by dopamine agonists
Neuroleptic Malignant Syndrome
symptoms of agitation, coma, muscle rigidity, tremors, high fever, and an unstable BP
COMT and MAO-B inhibitors
added to the regimen of dopamine agonists, further complications of dopamine will preciptate
Take carbidopa/levidopa
on an empty stomach
Antihypertensive agents with dopamine agonists
can cause severe hypotension
Phenelzine (MAO inhibitors) with dopamine agonists
can cause hypertensive crisis
Iron decreases the effects of
carbidopa/levodopa
B6 increases metabolism of
levodopa
Reglan decreases effectiveness of
dopamine agonists
Dopamine agonists with sedatives
worsen drowsiness
Akinesia
loss of movement